APVO: aptevotherapeutics.com Kompaniya qiymatining sof foydaga nisbati
Aptevo Therapeutics (APVO) tibbiy tadqiqotlar sanksiyalar va savdo mojarolaridan himoyalangan barqaror Shimoliy Amerika mintaqasida faoliyat yuritadi. Kompaniya immuno-onkologiya sektoridagi kengayishni jadallashtirish uchun ADAPTIR tizimi orqali o'zining bispesifik antitanalar portfelini kengaytirmoqda. Ushbu grafik 0.00 miqdoridagi P/E koeffitsiyentini aks ettiradi. Daromadlar Alphanate yetkazib berish bo'yicha hukumat shartnomalari va ixtisoslashtirilgan klinikalarga mo'ljallangan saraton terapiyalarini ishlab chiqish orqali shakllantiriladi.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwg3sw3k.w4s-7di3ke8&start=20220704&end=20261114&filename=GURU_Markets_-_APVO_-_Aptevo-Therapeutics_-_PE-Multiple "APVO: Aptevo Biznesning o‘zini qoplash muddati 04.07.2022 - 14.11.2026 | 👁️GURU.Markets👁️")
Aptevo Therapeutics, Inc. (APVO) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Aptevo Therapeutics|APVO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Aptevo|APVO - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Aptevo Therapeutics Inc.|APVO - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Aptevo Therapeutics|Tezkor likvidlik koeffitsiyenti aptevotherapeutics.com
- foyda va bozor multiplikatorlari tafsilotlari:
APVO - Kompaniyaning sof foydasi|Forvard foyda Aptevo Therapeutics|APVO - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning kelajakdagi foydaga nisbati Aptevo|APVO - PEG multiplikatori|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Aptevo Therapeutics Inc.|APVO - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Aptevo Therapeutics|APVO - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi aptevotherapeutics.com|APVO - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Aptevo Therapeutics
- realizatsiya hajmi va tushum ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:aptevotherapeutics.com APVO
P/E koeffitsiyenti bozor kapitalizatsiyasining sof foydaga nisbati sifatida hisoblanadi va yillik daromadning bir dollari uchun sarflangan xarajatni o'lchaydi. Ushbu koeffitsiyent biznesning haqiqiy pul oqimini yaratish qobiliyatini belgilaydi va fundamental past baholangan bosqichlarni aniqlaydi. Aptevo Therapeutics (APVO) uchun ushbu metrika R&D investitsiyalarining samaradorligini va aksiyalar opsionlari orqali olimlarning kompaniyada qolishini aks ettiradi. Kompaniyaga tegishli choraklik P/E koeffitsiyentini tahlil qilish aktivning xavfsizlik zaxirasini baholashga yordam beradi, egri chiziqning narx harakati esa optimal kirish nuqtalarini aniqlaydi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|AbCellera Bio - P/E multiplikatori|TRML - P/E multiplikatori|Precigen, Inc. (PGEN) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati PHAR (pharming.com)|Narx-foyda koeffitsiyenti NKTR|UPB (Upstream Bio, Inc.) - Bozor narxining sof foydaga nisbati|P/E multiplikatori ZBIO|IMNM - Kapitalizatsiyaning foydaga nisbati|Gossamer Bio, Inc. - Narx-foyda koeffitsiyenti|kalvista.com - Narxning foydaga nisbati|SEPN - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Pieris Pharma|SVRA (Savara Corp) - Narx-foyda koeffitsiyenti|Rigel Corp - Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti ANAB|ATXS (astriatx.com) - Bozor narxining sof foydaga nisbati|P/E multiplikatori ENGN|RAPT (RAPT Therapeutics Inc.) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori JBIO (Aerovate Therapeutics)|Aclaris Therapeutics, Inc (ACRS) - Kapitalizatsiyaning foydaga nisbati|KYTX - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati TLSA (tizianalifesciences.com)|CABA: P/E multiplikatori|Ventyx Biosciences Inc. (VTYX) - P/E multiplikatori|Narxning foydaga nisbati Theratechnologies Inc|Avalo Therapeutics Inc - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori ELDN|AGEN - Kapitalizatsiyaning foydaga nisbati|Climb Bio - Narx-foyda koeffitsiyenti|P/E multiplikatori Zura Bio Ltd ZURA|ATYR: Narx-foyda koeffitsiyenti|Adagene - Bozor narxining sof foydaga nisbati|IMA: P/E multiplikatori|STTK - Biznesning o‘zini qoplash muddati|EQ (Equillium Inc) - P/E multiplikatori|Narx-foyda koeffitsiyenti Connect Pharma (CNTB)|Narxning foydaga nisbati Immunic, Inc. (IMUX)|Biznesning o‘zini qoplash muddati atarabio.com|P/E multiplikatori IFRX (InflaRx)|P/E multiplikatori x4pharma.com XFOR|ACET - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati CELU|INMB (INmune Bio Corp) - Narx-foyda koeffitsiyenti|BRNS (Barinthus Biotherapeutics Corp) - Narxning foydaga nisbati|Narxning foydaga nisbati Kezar Life Sciences|Kapitalizatsiyaning foydaga nisbati sabbiotherapeutics.com SABS|Narxning foydaga nisbati Akari Therapeutics Plc (AKTX)|ENLV: Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori QTTB (Q32 Bio)|Kompaniya qiymatining sof foydaga nisbati GOVX|Edesa Biotech, Inc. - P/E multiplikatori|IBIO - P/E multiplikatori|carismatx.com (CARM) - Narxning foydaga nisbati|XTL Biopharmaceuticals Ltd - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Bolt Biotherapeutics Inc.|Narx-foyda koeffitsiyenti HCW Biologics Inc (HCWB)|P/E multiplikatori AIM|P/E multiplikatori aditxt.com (ADTX)|GRI Bio - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati XRTX|ReShape Lifesciences - P/E multiplikatori|Biznesning o‘zini qoplash muddati Revelation Biosciences Corp REVB|Indaptus Therapeutics (INDP) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti scinai.com|Narxning foydaga nisbati CalciMedica Inc|Narx-foyda koeffitsiyenti Affimed Therapeutics (AFMD)|Narx-foyda koeffitsiyenti ALLK (Allakos Inc.)|P/E multiplikatori hookipapharma.com (HOOK)|Narxning foydaga nisbati IGM Biosciences IGMS|ITOS: Narx-foyda multiplikatori|Ocean Biomedical - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati TC BioPharm (Holdings) Plc|THRD: P/E multiplikatori
